https://pubmed.ncbi.nlm.nih.gov/28249590/
Erratum to: Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant...
clear cellerratumtumorimmunemicroenvironment
https://www.pharmaceutical-technology.com/data-insights/npx-887-nextpoint-therapeutics-metastatic-renal-cell-carcinoma-likelihood-of-approval/
NPX-887 is under clinical development by NextPoint Therapeutics and currently in Phase I for Metastatic Renal Cell Carcinoma.
renal cell carcinomanpxtherapeuticsmetastatic
https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-metastatic-renal-cell-carcinoma/
Metastatic Renal Cell Carcinoma disease is an indication for drug development with over 130 pipeline drugs currently active according to GlobalData.
renal cell carcinomametastaticdrugslikelihoodapproval
https://www.scirp.org/journal/paperinformation?paperid=37424
Discover the potential benefits of combining Ang-2 targeted therapy with small molecule VEGF targeted agents in inhibiting tumor growth and angiogenesis in...
combinedangvegftargetingtherapies
https://www.biospace.com/calithera-biosciences-reports-cantata-study-of-telaglenastat-in-renal-cell-carcinoma-did-not-achieve-primary-endpoint
Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage biotechnology company focused on discovering and developing novel small-molecule drugs for the...
biosciencesreportscantatastudyrenal
https://pubmed.ncbi.nlm.nih.gov/30888953/
A 73-year-old man presented with a red papule on the posterior aspect of his neck (Figure 1). The growth had first been noted approximately 1 month before his...
renal cell carcinomacutaneousmetastasis
https://www.thehealthsite.com/diseases-conditions/suffering-from-type-2-diabetes-it-can-be-a-risk-factor-in-causation-of-renal-cell-carcinoma-853375/
Type-2 diabetes can lead to the onset of several diseases, including kidney diseases and cancer. Here is how diabetes can lead to renal cell carcinoma....
sufferingtypediabetesrisk
https://pubmed.ncbi.nlm.nih.gov/12953756/
Cytoreductive nephrectomy can be an important and effective component of a multidisciplinary treatment approach to metastatic renal cell carcinoma in carefully...
rolenephrectomymanagementmetastatic
https://pubmed.ncbi.nlm.nih.gov/30123592/
We report a rare case of metastatic renal cell carcinoma (RCC) in a patient who developed rhabdomyolysis while on sunitinib. He was admitted to the hospital...
rarecasesunitinibinducedrhabdomyolysis
https://www.mdpi.com/1660-4601/19/19/12471
SH3 and multiple ankyrin repeat domains (SHANK) is a family of scaffold proteins that were first identified to be involved in balancing synaptic transmission...
renal cell carcinomagenetic analysisdysregulation
https://pubmed.ncbi.nlm.nih.gov/41533299/?utm_source=SimplePie&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1zOrwYPa_1RS6jdZ9VLHcTFM_z0nKGv5xC17ijJBVjdDspZQ-I&fc=20220524062322&ff=20260114205402&v=2.18.0.post22+67771e2
HRQoL differed significantly between men and women six months after surgery, with men reporting higher HRQoL, even after accounting for clinical, demographic,...
sex differenceshealth relatedqualityliferenal
https://pubmed.ncbi.nlm.nih.gov/29988298/
Metastatic lesions of the nasal cavity and paranasal sinuses are rare tumors. Carcinomas originating from intrapelvic organs play an important role in the...
renal cell carcinomanasal septummetastaticcase
https://www.pharmaceutical-technology.com/data-insights/ab-2100-arsenal-biosciences-metastatic-renal-cell-carcinoma-likelihood-of-approval/
AB-2100 is under clinical development by Arsenal Biosciences and currently in Phase II for Metastatic Renal Cell Carcinoma.
renal cell carcinomaabarsenalbiosciencesmetastatic
https://www.pharmaceutical-technology.com/data-insights/afm-24i-affimed-metastatic-renal-cell-carcinoma-likelihood-of-approval/
AFM-24I is under clinical development by Affimed and currently in Phase II for Metastatic Renal Cell Carcinoma.
renal cell carcinomaafmmetastaticlikelihood
https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.776824/full
Clear cell renal cell carcinoma (ccRCC) is characterized by the inactivation of von Hippel-Lindau (VHL) gene. Of note, no other gene is mutated as frequently...
expressed genesclear cellrenal carcinomafrontiers
https://www.pharmaceutical-technology.com/data-insights/botensilimab-agenus-renal-cell-carcinoma-likelihood-of-approval/?utm_source=lgp5-loa&utm_medium=24-280739&utm_campaign=recommended-articles-pi
Botensilimab is under clinical development by Agenus and currently in Phase I for Renal Cell Carcinoma.
renal cell carcinomaagenuslikelihoodapproval
https://www.prweb.com/releases/new_research_looks_at_immunologic_therapy_of_renal_cell_carcinoma/prweb11884838.htm
(PRWEB UK) 3 June 2014 -- Oncology & Hematology Review, the peer-reviewed journal, publishes cutting-edge article on Immunologic Therapy of Renal Cell...
renal cell carcinomanew researchlooksimmunologictherapy
https://www.news-medical.net/news/20210212/Study-explores-impact-of-surgical-delay-for-renal-cell-carcinoma-during-COVID-19-pandemic.aspx
During the peak of the COVID-19 pandemic, several elective surgeries for renal cell carcinoma, the most common type of kidney cancer, were delayed with unknown...
renal cell carcinomastudyexploresimpactsurgical
https://www.pharmaceutical-technology.com/data-insights/imdatifan-nikang-therapeutics-metastatic-renal-cell-carcinoma-likelihood-of-approval/?utm_source=lgp5-loa&utm_medium=24-350811&utm_campaign=recommended-articles-pi
Imdatifan is under clinical development by NiKang Therapeutics and currently in Phase II for Metastatic Renal Cell Carcinoma.
renal cell carcinomatherapeuticsmetastaticlikelihood
https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2020.567970/full
ATP6V1s participate in the biological process of transporting hydrogen ions and are associated with various cancers in expression and clinicopathological fea...
comprehensive analysisfamily membersfrontiersrenalclear
https://pubmed.ncbi.nlm.nih.gov/41533299/?utm_source=SimplePie&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1zOrwYPa_1RS6jdZ9VLHcTFM_z0nKGv5xC17ijJBVjdDspZQ-I&fc=20220524062322&ff=20260114165030&v=2.18.0.post22+67771e2
HRQoL differed significantly between men and women six months after surgery, with men reporting higher HRQoL, even after accounting for clinical, demographic,...
sex differenceshealth relatedqualityliferenal
https://www.hugendubel.de/de/buch_gebunden/an_integrated_approach_to_renal_cell_carcinoma-23612341-produkt-details.html
Entdecken Sie "An Integrated Approach to Renal Cell Carcinoma" als Buch (gebunden) | Kostenloser Versand | Jetzt kaufen auf Hugendubel.de!
renal cell carcinomaintegrated approachonline kaufen
https://scirp.org/journal/paperinformation?paperid=77270
Discover a rare case of cutaneous metastasis in a 49-year-old woman with renal cell carcinoma. Learn about the treatment involving surgical excision and...
renal cell carcinomacase reportcutaneousmetastasis
https://www.aging-us.com/figure/102660/f5
CDH1, CDH2, SNAI1, SNAI2 and TWIST1 significantly involved in stromal process of ccRCC tumor environment. EMT makers, including CDH1 (A), CDH2 (B), SNAI1 (C),...
clear cellprognosticvalueepithelialmesenchymal
https://pubmed.ncbi.nlm.nih.gov/36788716/
The significant positive association of DFS and OS among patients with intermediate-high risk and high risk RCC post-nephrectomy from this study supports the...
diseasefreesurvivalpredictoroverall
https://clarivate.com/life-sciences-healthcare/report/dlsfon0009-2025-biopharma-renal-cell-carcinoma-disease-landscape-forecast-g7-2025/
The renal cell carcinoma therapy market is rapidly evolving and experiencing substantial growth, largely driven by the increasing uptake of immune checkpoint...
renal cell carcinomadiseaselandscapeforecastclarivate